首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1630648

脂漏性皮膚炎治療藥物市場規模、佔有率、成長分析，按類型、按治療、按劑型、按分銷管道、按地區 - 行業預測，2025-2032 年

Seborrheic Dermatitis Treatment Market Size, Share, Growth Analysis, By Type (Prescription Based Drugs, Over the Counter Drugs), By Treatment (Anti-fungal, Antibiotics), By Dosage form, By Distribution channel, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月09日 | 出版商:

SkyQuest | 英文 217 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球脂漏性皮膚炎藥物市場規模價值 27.2 億美元，預計將從 2024 年的 30.2 億美元成長到 2032 年的 70.1 億美元，預測期內（2025-2032 年）的複合年成長率為 11.1%。

受醫療保健技術進步、乾癬和愛滋病毒等自體免疫疾病發病率上升以及研究活動活性化的推動，全球脂漏性皮膚炎治療市場正在經歷顯著成長。皮膚科診所的快速增加以及藥用洗髮精、乳液、凝膠和泡沫等各種治療選擇的出現，極大地促進了市場的擴張。通常建議使用含有抗真菌劑（例如硫化硒）的藥用洗髮精來控制症狀。此外，該產業正重視聯盟、收購和夥伴關係，以增強市場動態。隨著人們對自我護理和個人健康的關注度不斷提高，皮膚病學正在成為一門重要的醫學專業。紫外線療法和皮膚病診斷軟體等創新進一步豐富了治療領域，並擴大了對脂漏性皮膚炎解決方案的需求。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分析市場佔有率
- 收益與前一年同期比較（2022-2024 年）

主要企業簡介

Arcutis Biotherapeutics（USA）
Sonoma Pharmaceuticals（USA）
Merck & Co., Inc.（USA）
Hikma Pharmaceuticals（UK）
GlaxoSmithKline plc（UK）
Bausch Health Companies Inc.（Canada）
Almirall SA（Spain）
Aurobindo Pharma Ltd.（India）
Leo Pharma A/S（Denmark）
Lupin Limited（India）
Medimetriks Pharmaceutical Inc.（USA）
Sun Pharmaceutical Industries Ltd.（India）
Johnson & Johnson（USA）
Novartis AG（Switzerland）
Bayer AG（Germany）
Teva Pharmaceutical Industries Ltd.（Israel）
Sanofi SA（France）
F. Hoffmann-La Roche AG（Switzerland）
Pfizer Inc.（USA）
AbbVie Inc.（USA）

結論和建議

簡介目錄

Product Code: SQMIG35D2239

Global Seborrheic Dermatitis Treatment Market size was valued at USD 2.72 billion in 2023 and is poised to grow from USD 3.02 billion in 2024 to USD 7.01 billion by 2032, growing at a CAGR of 11.1% during the forecast period (2025-2032).

The global market for seborrheic dermatitis treatments is witnessing substantial growth, driven by technological advancements in healthcare, a rising incidence of autoimmune disorders like psoriasis and HIV, and increased research activities. The proliferation of dermatological clinics and a diverse range of treatment options, including medicated shampoos, lotions, gels, and foams, significantly contribute to market expansion. Medicated shampoos with antifungal agents such as selenium sulfide are commonly recommended for managing symptoms. Furthermore, the industry's focus on collaborations, acquisitions, and partnerships enhances market dynamics. As self-care and personal well-being gain prominence, dermatology emerges as a leading medical specialty. Innovations like UV therapy and software for skin condition diagnosis are further enriching the treatment landscape, amplifying demand for seborrheic dermatitis solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Seborrheic Dermatitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Seborrheic Dermatitis Treatment Market Segmental Analysis

Global Seborrheic Dermatitis Treatment Market is segmented by Type, Treatment, Dosage form, Distribution channel and region. Based on Type, the market is segmented into Prescription Based Drugs and Over the Counter Drugs. Based on Treatment, the market is segmented into Anti-fungal, Antibiotics, Anti inflammatory, and Others. Based on Dosage form, the market is segmented into Shampoo, Cream, Ointment, Tablet and Others. Based on Distribution channel, the market is segmented into Hospital Pharmacy, Retail pharmacy and Online Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Seborrheic Dermatitis Treatment Market

One significant driver propelling the global seborrheic dermatitis treatment market is the rising investment in treatment infrastructure. As healthcare costs continue to escalate, there is a greater push towards enhancing the industry's framework, which facilitates improved access to effective treatments. Moreover, various government entities are amplifying their funding efforts to bolster healthcare infrastructure, which is set to positively influence market dynamics. This renewed focus on investment not only aids in the development of advanced therapeutic solutions but also contributes to the overall growth and evolution of the seborrheic dermatitis treatment landscape, addressing the increasing demand for better healthcare services.

Restraints in the Global Seborrheic Dermatitis Treatment Market

The Global Seborrheic Dermatitis Treatment market faces several restraints that could impede its growth trajectory. High treatment costs are a significant barrier, particularly affecting patient access and affordability. In emerging nations, inadequate healthcare infrastructure and a scarcity of primary care services create additional challenges, limiting the reach of effective treatments. Moreover, during the forecast period from 2022 to 2029, stringent regulatory frameworks and insufficient public awareness regarding seborrheic dermatitis may further constrain the market's expansion. Collectively, these factors are likely to restrict the rate at which the market can grow, impacting overall accessibility and treatment options.

Market Trends of the Global Seborrheic Dermatitis Treatment Market

The Global Seborrheic Dermatitis Treatment market is witnessing a significant trend characterized by advancements in topical treatments aimed at resolving the underlying causes of this persistent skin condition. Pharmaceutical companies are heavily investing in innovative formulations, including creams, shampoos, and foams that incorporate a range of effective agents such as keratolytics, corticosteroids, and antifungals. These novel treatments not only target inflammation but also address the yeast overgrowth associated with seborrheic dermatitis, making them more effective in managing the symptoms. This shift towards more specialized and targeted therapies is expected to drive market growth and enhance patient outcomes, reflecting a growing commitment to improved skincare solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Seborrheic Dermatitis Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Prescription Based Drugs
Over the Counter Drugs

Global Seborrheic Dermatitis Treatment Market Size by Treatment & CAGR (2025-2032)

Market Overview
Anti-fungal
Antibiotics
Anti inflammatory
Others

Global Seborrheic Dermatitis Treatment Market Size by Dosage form & CAGR (2025-2032)

Market Overview
Shampoo
Cream
Ointment
Tablet
Others

Global Seborrheic Dermatitis Treatment Market Size by Distribution channel & CAGR (2025-2032)

Market Overview
Hospital Pharmacy
Retail pharmacy
Online Pharmacy

Global Seborrheic Dermatitis Treatment Market Size & CAGR (2025-2032)

North America (Type, Treatment, Dosage form, Distribution channel)
- US
- Canada
Europe (Type, Treatment, Dosage form, Distribution channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Treatment, Dosage form, Distribution channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Treatment, Dosage form, Distribution channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Treatment, Dosage form, Distribution channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Arcutis Biotherapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonoma Pharmaceuticals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hikma Pharmaceuticals (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Health Companies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almirall S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurobindo Pharma Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leo Pharma A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medimetriks Pharmaceutical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments